RxDoctor Payments Data

Boris Leheta

Neurology · Roseville, MINPI 1891724894

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 387 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $2,354 and has fallen 97.9% since, to $50 in 2024.

$6,319in general payments, 2019–2025

Across 387 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$730
  • EMD Serono, Inc.$506
  • Novartis$456
  • UCB, Inc.$409
  • AbbVie$376
  • Sanofi$355
  • plus $3K from 38 others

What the payments were for

  • Speaking & faculty fees$150%
  • Food & beverage$6,304100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,319 in reported general payments places this provider in the 75th percentile of 652 neurology providers in Michigan.

See all neurology providers in Michigan →

Other neurology in Roseville

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →